PMEF
FLGT icon

Point72 Middle East FZE’s Fulgent Genetics FLGT Stock Holding History

Point72 Middle East FZE’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,967
Closed -$106K – 1620
2023
Q3 		$106K Buy
3,967
+1,470
+59% +$50.2K ﹤0.01% 1134
2023
Q2 		$92.5K Buy
2,497
+1,789
+253% +$62.4K ﹤0.01% 1216
2023
Q1 		$22.1K Sell
708
-1,933
-73% -$62.2K ﹤0.01% 1414
2022
Q4 		$78.6K Buy
+2,641
New +$94.5K ﹤0.01% 1349

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Point72 Middle East FZE's FLGT Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 3,967 shares — an estimated $106K sold.

Point72 Middle East FZE first reported a position in FLGT in Q4 2022 and held it in 4 quarters. The position peaked at $106K in Q3 2023. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 3,967 Fulgent Genetics shares in Q4 2023, an estimated $106K.
  • Point72 Middle East FZE first reported a position in Fulgent Genetics in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's Fulgent Genetics position peaked at $106K in Q3 2023.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.